Atopic dermatitis (AD), also known as eczema, is a common skin disorder. Symptoms can include flaky skin lesions and intense itching. An estimated 10% of adults and up to 20% of children suffer from AD. AD can unpredictably flare in adolescence and in adulthood.
People with mild or moderate atopic dermatitis, (a.k.a. eczema) may be eligible to join this research study of an investigational medication for the condition. Eligible participants may receive compensation for time and travel, as well as study-related care at no cost.
- Must be age 18 to 75
- Must have mild to moderate eczema for 3+ weeks
- May receive compensation for study-related time and travel.
- Do not need insurance to join this study
For more information, complete the form on this page. After you submit your information, a Meridian enrollment specialist will call you to talk about the study. There is no obligation to join — you can decide if the study is right for you.
You can also talk to a Meridian enrollment specialist about this study by calling (402) 934-7563 (Meridian call center).
Meridian Clinical Research
5326 O'Donovan Dr.
Baton Rouge, LA 70808
Submit your information...